Rechercher des projets européens

7 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

STRATEGY TO INHIBIT TGF-Beta IN LIVER DISEASE (IT-LIVER)

Date du début: 1 oct. 2012, Date de fin: 30 sept. 2016,

Chronic liver diseases (CLD) and their end-stages, cirrhosis and hepatocellular carcinoma (HCC), are leading causes of morbidity and mortality worldwide with enormous socio-economic costs. Patients with liver cirrhosis are at high risk of deadly hepatic failure and over 80% of HCC develop on a cirrhotic background. HCC ranks as the 5th most common cancer and with >600,000 deaths per annum it const ...
Voir le projet

 12

 TERMINÉ 
Novel transplant regimens are currently being developed to improve beneficial GvL effects and reduce GvHD and infections via several new forms of cellular therapies. This newly emerging supra-disciplinary field of cellular therapy and regenerative medicine is also being used to improve outcomes in autoimmune disease (such as Rheumatoid Arthritis) and cancers. The goal of this research programme is ...
Voir le projet

 13

 TERMINÉ 
MARCAR aims to establish reliable early markers and molecular classification of tumors in non genotoxic carcinogenesis, applying a mechanism-based approach. Benefits are improved drug safety, more efficient drug development, and progress with 3 R issues. MARCAR focuses on rodent liver, the major target organ of non-genotoxic carcinogens (NGC). However, this approach will facilitate predictions for ...
Voir le projet

 12

 TERMINÉ 

EUROCANCER STEMCELL TRAINING NETWORK (EuroCSCTraining)

Date du début: 1 janv. 2011, Date de fin: 31 déc. 2014,

The recent identification of tumor initiating (TIC) or cancer stem cells (CSC) has opened a new area of research for scientists interested in cancer. Understanding the biology of cancer stem cells has already unraveled pathways and potential targets. However, accumulating data has underscored the complexity of the CSC research area and prompts hence the need for well-structured networks to provid ...
Voir le projet

 11

 TERMINÉ 
CytoThreat addresses the need to assess the risks of pharmaceuticals released in the environment, focusing on cytostatic drugs because they are highly hazardous compounds due to their genotoxic properties which may cause unexpected long term effects. Their release in the environment may lead to systemic ecological effects and increased cancer incidence, reduced fertility and malformations in the o ...
Voir le projet

 9

 TERMINÉ 
Advanced Therapy Medicinal Products (ATMPs) are medicinal products for human use, based on gene therapy, somatic cell therapy or tissue engineering. A rapidly growing area in translational research, they represent the ‘next generation’ of complex medicines for complex diseases and pose particular challenges to medicines regulation.Regulation (EC) No 1394/2007 has been designed to ensure the free m ...
Voir le projet

 9

 TERMINÉ 

Supporting Energy Efficiency in Smart Generation Grids through ICT (SEESGEN-ICT)

Date du début: 1 juin 2009, Date de fin: 31 mai 2011,

Designing ICT for managing the smart grids with integrated microgrids is a challenge that cannot be won by a single utility, industry or country. It requires collaboration of all Stakeholders, in an interdisciplinary approach that brings together experiences from the different countries with their different situations and from different viewpoints, in order to contribute to a scalable system that ...
Voir le projet

 24